Home » Topics » BioWorld

BioWorld
RSS

TSI GETS LICENSE FROM CELLGENESYS

Oct. 2, 1992

RAGGIO FIGHTS TERMINATION OF LICENSE PACT

Oct. 2, 1992

CEPHALON REPORTS SAFETY DATA

Oct. 2, 1992

CLASS OF '92 FACED A TOUGH MARKET

Oct. 2, 1992

BIOTECHNICA ACQUIRES FACILITY

Oct. 2, 1992

ACQUISITION EXPANDS ATS TECHNOLOGY

Oct. 2, 1992

GLYCOMED COMPLETES SAFETY TRIALS OF EYE DRUG

Oct. 1, 1992

RIGHTS TO PROTEASE INHIBITOR ASSIGNED TO INCYTE

Oct. 1, 1992

RESEARCHERS SHARE UNPUBLISHED GENOME DATA

Oct. 1, 1992

FDA APPROVES IN-OFFICE TEST

Oct. 1, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...